Your browser doesn't support javascript.
loading
Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma.
Xu, Li; Wang, Yingcong; Wang, Guanli; Guo, Shushan; Yu, Dandan; Feng, Qilin; Hu, Ke; Chen, Gege; Li, Bo; Xu, Zhijian; Jia, Xinyan; Lu, Yumeng; Zhang, Hui; Gao, Xuejie; Chang, Shuaikang; Wang, Huaping; Wu, Xiaosong; Song, Dongliang; Yang, Guang; Zhu, Huabin; Zhou, Jinfeng; Zhan, Fenghuang; Zhu, Weiliang; Shi, Jumei.
Afiliação
  • Xu L; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Wang Y; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
  • Wang G; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Guo S; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Yu D; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
  • Feng Q; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Hu K; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Chen G; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Li B; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
  • Xu Z; CAS Key Laboratory of Receptor Research; State Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Jia X; CAS Key Laboratory of Receptor Research; State Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Lu Y; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Zhang H; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
  • Gao X; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Chang S; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Wang H; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Wu X; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
  • Song D; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
  • Yang G; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Zhu H; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Zhou J; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
  • Zhan F; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Zhu W; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
  • Shi J; CAS Key Laboratory of Receptor Research; State Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
Leukemia ; 37(7): 1576-1579, 2023 07.
Article em En | MEDLINE | ID: mdl-37157015
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article